Matrix metalloproteinase (mmp) inhibitors and methods of use thereof
AssigneeForesee Pharmaceuticals Co., Ltd.
InventorsWenjin YANG, Kai-Wei CHANG
Life of this patent
Estimating the term…
Loading patent…
AssigneeForesee Pharmaceuticals Co., Ltd.
InventorsWenjin YANG, Kai-Wei CHANG
Estimating the term…
Hydantoin based compounds useful as inhibitors of matrix metalloproteinases (MMPs), particularly macrophage elastase (MMP-12) are described. Also described are related compositions and methods of using the compounds to inhibit MMP-12 and treat diseases mediated by MMP-12, such as asthma, chronic obstructive pulmonary disease (COPD), emphysema, acute lung injury, idiopathic pulmonary fibrosis (IPF), sarcoidosis, systemic sclerosis, liver fibrosis, nonalcoholic steatohepatitis (NASH), arthritis, cancer, heart disease, inflammatory bowel disease (IBD), acute kidney injury (AKI), chronic kidney disease (CKD), Alport syndrome, and nephritis.
A compound of formula (I):
A compound selected from the group consisting of:
(canceled)
Dependencies are inferred from the claim text.